BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3556094)

  • 21. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of anafranil in obsessive compulsive disorder. Recent clinical findings.
    Katz RJ; Landau P; DeVeaugh-Geiss J; Hakkarainen H
    Prog Clin Biol Res; 1990; 361():489-93. PubMed ID: 2149765
    [No Abstract]   [Full Text] [Related]  

  • 24. Clomipramine in obsessive-compulsive disorder: a review.
    Ananth J
    Psychosomatics; 1983 Aug; 24(8):723-7. PubMed ID: 6356210
    [No Abstract]   [Full Text] [Related]  

  • 25. Rebound withdrawal reactions due to clomipramine.
    Diamond BI; Borison RL; Katz R; DeVeaugh-Geiss J
    Psychopharmacol Bull; 1989; 25(2):209-12. PubMed ID: 2690164
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clomipramine in obsessive compulsive disorder.
    Lee S
    J Clin Psychiatry; 1991 Apr; 52(4):183-5. PubMed ID: 2016256
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin and effect sizes of antiobsessive agents.
    Pato MT; Gluhoski V
    Am J Psychiatry; 1992 Mar; 149(3):420-1. PubMed ID: 1531582
    [No Abstract]   [Full Text] [Related]  

  • 31. Obsessional compulsive neurosis--a method of treatment.
    Perera HV
    Ceylon Med J; 1981 Dec; 26(4):169-72. PubMed ID: 7348612
    [No Abstract]   [Full Text] [Related]  

  • 32. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
    Luscombe DK; Wright J; Stern RS; Mawson D; Marks IM
    Postgrad Med J; 1980; 56 Suppl 1():140-3. PubMed ID: 7393825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory.
    Dominguez RA; Jacobson AF; de la Gandara J; Goldstein BJ; Steinbook RM
    Psychopharmacol Bull; 1989; 25(2):215-8. PubMed ID: 2602515
    [No Abstract]   [Full Text] [Related]  

  • 37. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amitriptyline therapy of obsessive-compulsive neurosis.
    Snyder S
    J Clin Psychiatry; 1980 Aug; 41(8):286-9. PubMed ID: 7400108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Double-blind trial treatment of anxiety with b 5833].
    Cloquette R
    Acta Psychiatr Belg; 1974 May; 74(3):317-26. PubMed ID: 4156149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.